Ncardia Launches iPSC-Based Phenotypic Screening Service to Bring Human Disease Biology Earlier into Drug Discovery and Development
LEIDEN, Netherlands–(BUSINESS WIRE)– Ncardia, a leading provider of human iPSC-derived cell-based assays and services for drug discovery and development, announced today the launch of their...